Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,248 | -67,901 | -57,992 | -47,059 | -32,830 |
| Depreciation Amortization | 8,181 | 8,979 | 11,692 | 12,269 | 8,782 |
| Accounts receivable | 538 | 21,742 | -22,562 | 3,492 | -38 |
| Other Working Capital | -2,710 | 15,842 | 5,938 | -971 | 3,958 |
| Other Operating Activity | 9,222 | -21,521 | 23,763 | -2,307 | 2,906 |
| Operating Cash Flow | $-71,017 | $-42,859 | $-39,161 | $-34,577 | $-17,222 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 39,120 | 440 | 36,961 | 25,983 | -71,792 |
| PPE Investments | -14,230 | -3,512 | -4,407 | -17,271 | -24,319 |
| Other Investing Activity | 166 | 186 | 785 | 226 | -1,504 |
| Investing Cash Flow | $25,056 | $-2,886 | $33,339 | $8,937 | $-97,615 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -44 | -365 | -492 |
| Common Stock Issued | 345,224 | 49,340 | 4,080 | 892 | 525 |
| Common Stock Repurchased | N/A | N/A | N/A | -23,070 | N/A |
| Other Financing Activity | 0 | 11,500 | 0 | 46,784 | 0 |
| Financing Cash Flow | $345,224 | $60,840 | $4,036 | $24,240 | $32 |
| Beginning Cash Position | 73,781 | 58,686 | 60,472 | 61,871 | 176,677 |
| End Cash Position | 373,044 | 73,781 | 58,686 | 60,472 | 61,871 |
| Net Cash Flow | $299,263 | $15,095 | $-1,786 | $-1,399 | $-114,805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,017 | -42,859 | -39,161 | -34,577 | -17,222 |
| Capital Expenditure | -14,231 | -3,581 | -4,415 | -17,286 | -24,325 |
| Free Cash Flow | -85,248 | -46,440 | -43,576 | -51,863 | -41,548 |